Allspring Global Investments Holdings, LLC Recursion Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 3,758 shares of RXRX stock, worth $29,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,758Holding current value
$29,312% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$256 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$197 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$135 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$120 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.41B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...